Position in JNJ
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$10,246,924
+$1,252,877 QoQ
Shares Held
41,920
-3.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.64%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026EXENCIAL WEALTH ADVISORS, LLC holds $76,718,350 across 13 Drug Manufacturers - General names. JNJ ranks #3 (13.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVS |
Novartis AG
|
108,594 | $16,587,733 | |
| 2 | LLY |
ELI LILLY & Co
|
17,141 | $15,765,777 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
41,920 | $10,246,924 | |
| 4 | ABBV |
AbbVie Inc.
|
41,150 | $8,949,713 | |
| 5 | AMGN |
Amgen Inc
|
17,401 | $6,122,541 | |
| 6 | AZN |
Astrazeneca PLC
|
20,162 | $3,976,349 | |
| 7 | SNY |
Sanofi
|
81,382 | $3,920,984 | |
| 8 | GSK |
GSK plc
|
55,198 | $3,046,377 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,246,924 | 41,920 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $8,994,047 | 43,460 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $8,129,925 | 43,846 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $7,954,914 | 52,078 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $6,934,433 | 41,814 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $6,446,147 | 44,573 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $7,061,440 | 43,573 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $6,594,885 | 45,121 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $7,429,076 | 46,963 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $7,618,347 | 48,605 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $7,104,380 | 45,614 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $8,111,473 | 49,006 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $7,044,440 | 45,448 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $8,115,301 | 45,940 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $6,748,564 | 41,311 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $7,283,235 | 41,030 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $7,045,069 | 39,751 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $7,562,662 | 44,208 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $8,554,009 | 52,966 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $6,850,548 | 41,584 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $7,520,162 | 45,757 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $6,930,543 | 44,037 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $10,488,000 | 70,446 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $6,547,451 | 46,558 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $2,819,819 | 21,504 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||